NovAliX Conference 2013 <br />Biophysics in Drug Discovery

Confirmed Speakers


Confirmed Speakers

KN01 - Biophysical Methods and Fragment Based Drug Discovery: Targeting Protein-Protein Interactions in Cell Regulatory Systems
Prof. Sir Tom BLUNDELLProf. Sir Tom BLUNDELL
(UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)

Read more
PL04 - Protein Methyltransferase Inhibitors as Personalised Cancer Therapeutics: DOT1L and EPZ-5676
Dr Ann BORIACK-SJODIN
(EPIZYME, Cambridge, United States)

Read more
PL08 - Backscattering Interferometry: An Enabling Drug Development Technology
Dr Darryl BORNHOPDr Darryl BORNHOP
(VANDERBILT UNIVERSITY, Nashville, United States)

Read more
KN03 - Combining X-Ray Crystallography and Single-Molecule Methods to Probe Antibiotic Inhibition of Translation
Prof. Jamie CATEProf. Jamie CATE
(UNIVERSITY OF CALIFORNIA, Berkeley, United States)

Read more
PL02 - Enabling GPCR Drug Discovery Through Structural and Biophysical Insights
Dr Rob COOKEDr Rob COOKE
(HEPTARES, Hertfordshire, United Kingdom)

Read more
PL10 - Application of SPR Biosensors Throughout the Drug Discovery Process
Prof. Helena DANIELSONProf. Helena DANIELSON
(UPPSALA UNIVERSITY, Uppsala, Sweden)

Read more
PL07 - Label-Free, Immobilisation-Free Interaction Studies Using Microscale Thermophoresis
Dr Stefan DUHRDr Stefan DUHR
(NANOTEMPER, Munich, Germany)

Read more
PL03 - Biophysics to Drive Lead Discovery
Dr Matthias FRECHDr Matthias FRECH
(MERCK, Darmstadt, Germany)

Read more
PL01 - Binding of Drug Substances to Molecular Targets Investigated by Biophysical Methods
Dr Michael HENNIGDr Michael HENNIG
(F. HOFFMANN-LA ROCHE LTD., Villigen, Switzerland)

Read more
PL06 - Can we Use Kinetics and Thermodynamics to Guide Drug Discovery?
Dr Geoff HOLDGATEDr Geoff HOLDGATE
(ASTRAZENECA, Macclesfield, United Kingdom)

Read more
PL09 - Towards Personalised Cancer Medicine with New NMR Tools to Probe Small GTPase Proteins
Dr Chris MARSHALLDr Chris MARSHALL
(UNIVERSITY OF TORONTO, Toronto, Canada)

Read more
PL11 - Finding Active Ligands to kRAS Using Solution State NMR
Dr Till MAURERDr Till MAURER
(GENENTECH, South San Francisco, United States)

Read more
PL12 - Biophysics in Pharmaceutical Lead Discovery
Dr Johannes OTTLDr Johannes OTTL
(NOVARTIS INSTITUTE OF BIOMEDICAL RESEARCH, Basel, Switzerland)

Read more
KN02 - Molecular Mechanism of Action (MMOA) in Drug Discovery
Dr David SWINNEYDr David SWINNEY
(IRND3, Mountain View, United States)

Read more
PL05 - Investing in Knowledge: Combining Biophysical Data in Fragment-Based Drug Discovery
Dr Glyn WILLIAMSDr Glyn WILLIAMS
(ASTEX PHARMACEUTICALS, Cambridge, United Kingdom)

Read more

Oral Communications

OC09 - Identification and Validation of Small Molecule Inhibitors of G Protein Beta 1 Gamma 2
Dr Preeti BAKRANIA
(MRC TECHNOLOGY, London, United Kingdom)
OC01 - Biophysical Investigations of the Synergistic Activities of Antimicrobial Peptides: New Strategies to Fight Multiresistance
Prof. Burkhard BECHINGER
(UNIVERSITY OF STRASBOURG, Strasbourg, France)
OC05 - Bringing Light into Antibody Binding Characteristics in Crude Extracts by Means of FCCS
Dr Frank BECKERDr Frank BECKER
(INTANA BIOSCIENCE GMBH, Planegg, Germany)
OC04 - Pharmacokinetics and the Drug-Target Residence Time Concept
Dr Göran DAHLDr Göran DAHL
(ASTRAZENECA, Mölndal, Sweden)
OC02 - X-Ray Crystallography, Kinetic Target-Guided Synthesis and NMR to Unravel the Mode of Action of Insulin Degrading Enzyme Modulators
Prof. Rebecca DEPREZ-POULAINProf. Rebecca DEPREZ-POULAIN
(UNIVERSITY OF LILLE, Lille, France)
OC07 - Binding Rate Constants Measured on Microliter Volume Using On-Chip Temperature Modulation and Fluorescence Lock-In Detection
Dr Charlie GOSSE
(CNRS, Marcoussis, France)
OC03 - Residence and Recognition Time and their Use for Structure Kinetic Relationships and for Judging Efficacy of Lead Series
Dr Markku HÄMÄLÄINEN
(GE HEALTHCARE BIO-SCIENCES, Uppsala, Sweden)
OC10 - Fragments at UCB: Implementation of Non-Covalent Mass Spectrometry and 19F NMR as Orthogonal Screening Techniques
Dr Hannah MAPLE
(UCB, Slough, United Kingdom)
OC06 - Detection and Analysis of Proteins with an Electro-Switchable DNA Chip
Dr Ralf STRASSER
(DYNAMIC BIOSENSORS GMBH, Martinsried, Germany)
OC08 - CRYO-TEM: The Way to Answer Real Biological Questions through Unraveling the 3D Mechanistics of Protein
Dr Thomas WOHLFARTH
(FEI, Eindhoven/Acht, The Netherlands)

Organised by

Sponsors

Exhibitors

Media Partners

Copyright 2019 LD Organisation sprl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys